ScholarGate
Asistent

Porovnat metody

Prohlédněte si vybrané metody vedle sebe; řádky, které se liší, jsou zvýrazněny.

Diagnostická kritéria Rome IV pro syndrom dráždivého tračníku×Dotazník pro pacienty s nespecifickými střevními záněty (IBD) – krátká verze×
OborGastroenterologieGastroenterologie
RodinaProcess / pipelineProcess / pipeline
Rok vzniku20162004
TvůrceRome Foundation (multinational expert consensus)Guyonnet, D., Chassany, O., Ducroc, R., et al.
TypDiagnostic CriteriaSelf-report
Původní zdrojMearin, F., Lacy, B. E., Chang, L., et al. (2016). Bowel disorders. Gastroenterology. Published online June 2016 by the Rome Foundation. link ↗Guyonnet, D., Chassany, O., Ducroc, R., Picard, C., Mouret, M., D'Haens, G., & Svartz, H. (2004). Effect of fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in France: A multicentre, randomized, double-blind, controlled trial. Alimentary Pharmacology & Therapeutics, 20(4), 459–465. link ↗
Další názvyRome IV IBS, Rome CriteriaIBDQ-32, Short IBDQ
Příbuzné44
ShrnutíThe Rome IV criteria are the internationally accepted diagnostic standard for irritable bowel syndrome (IBS), published in 2016 by the Rome Foundation. These criteria define IBS as recurrent abdominal pain (≥1 day per week for ≥3 months) associated with altered bowel habits, without structural or biochemical abnormalities. IBS is subtyped into four patterns—IBS-constipation predominant (IBS-C), IBS-diarrhea predominant (IBS-D), IBS-mixed (IBS-M), and IBS-unclassified (IBS-U)—based on stool consistency patterns.The Short Inflammatory Bowel Disease Questionnaire (IBDQ-32) is a validated patient-reported outcome measure designed to assess the impact of inflammatory bowel disease (IBD)—both ulcerative colitis and Crohn's disease—on health-related quality of life. Derived from the original 32-item IBDQ, this instrument comprises four domains: Bowel Symptoms, Systemic Symptoms, Social Function, and Emotional Function. The IBDQ-32 is responsive to treatment and is increasingly used in IBD clinical trials and practice.
ScholarGateDatová sada
  1. v1
  2. 1 Zdroje
  3. PUBLISHED
  1. v1
  2. 1 Zdroje
  3. PUBLISHED

Přejít na hledání Stáhnout prezentaci

ScholarGatePorovnat metody: Rome IV Irritable Bowel Syndrome Criteria · Short Inflammatory Bowel Disease Questionnaire. Získáno 2026-06-20 z https://scholargate.app/cs/compare